Arturo Arias1, Lilian Torres-Tobar2, Gualberto Hernández2, Deyanira Paipilla3, Eduardo Palacios4, Yahaira Torres3, Julian Duran5, Sebastian Ugarte U6, Adriana Ardila-Sierra7, Gabriel Castellanos8. 1. Intensive Care Unit, Clínica Norte, Cúcuta, Norte de Santander, Colombia, Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia. 2. Fundación Universitaria de Ciencias de la Salud, Grupo Ciencias Básicas en Salud, Bogotá, Colombia. 3. SOMEFYR, Cúcuta, Colombia. 4. Neurology Department, Hospital de San José-Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia. 5. Intensive Care Unit, Clínica Norte, Cúcuta, Colombia. 6. Jefe Centro de Pacientes Críticos, Clínica Indisa-Universidad Andrés Bello, Viña del Mar, Chile. 7. Research Division, Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia. 8. Research Division, Fundación Universitaria de Ciencias de la Salud, Bogotá, Colombia. Electronic address: gcastellanos@fucsalud.edu.co.
Abstract
PURPOSE: Zika virus (ZIKV) infection is an emerging global threat and a public health problem in the Americas. Guillain-Barré syndrome (GBS) has been recently associated to ZIKV. This report presents a case series of GBS possibly associated to ZIKV. METHODS: Clinical and demographic data from patients with GBS treated in 5 intensive care units and with recent history of ZIKV in Cúcuta, Colombia were collected from December 1 2015 to April 30 2016. Electrophysiological examination, lumbar puncture, and reverse transcriptase-polymerase chain reaction for ZIKV were performed in 14, 10, and 1 patients, respectively. RESULTS: Nineteen patients with GBS and a recent history of acute viral syndrome compatible with ZIKV infection were studied (mean age, 44 years; range, 17-78). Neurologic symptoms developed at a median of 10 days after the onset of the viral symptoms. Albuminocytological dissociation was found in 8 cases. Electrophysiological criteria for acute motor axonal neuropathy were found in all patients tested. Five patients met level 1, 8 patients level 2, and 6 patients level 3 of diagnostic certainty for GBS in the Brighton classification. Fifteen patients required respiratory assistance, 16 received intravenous immunoglobulins, and 3 had plasmapheresis. Seventy-nine percent of patients were in Hughes GBS disability scale 4 to 5 at discharge and no patients died during the observation period. Acute ZIKV infection, confirmed by reverse transcriptase-polymerase chain reaction, was observed for 1 patient. CONCLUSIONS: All cases of this GBS outbreak had a recent history ZIKV infection, reinforcing existing evidence for the association between GBS and ZIKV. Future genetic and immunologic studies are warranted to further investigate the cause of the outbreak in detail.
PURPOSE:Zika virus (ZIKV) infection is an emerging global threat and a public health problem in the Americas. Guillain-Barré syndrome (GBS) has been recently associated to ZIKV. This report presents a case series of GBS possibly associated to ZIKV. METHODS: Clinical and demographic data from patients with GBS treated in 5 intensive care units and with recent history of ZIKV in Cúcuta, Colombia were collected from December 1 2015 to April 30 2016. Electrophysiological examination, lumbar puncture, and reverse transcriptase-polymerase chain reaction for ZIKV were performed in 14, 10, and 1 patients, respectively. RESULTS: Nineteen patients with GBS and a recent history of acute viral syndrome compatible with ZIKV infection were studied (mean age, 44 years; range, 17-78). Neurologic symptoms developed at a median of 10 days after the onset of the viral symptoms. Albuminocytological dissociation was found in 8 cases. Electrophysiological criteria for acute motor axonal neuropathy were found in all patients tested. Five patients met level 1, 8 patients level 2, and 6 patients level 3 of diagnostic certainty for GBS in the Brighton classification. Fifteen patients required respiratory assistance, 16 received intravenous immunoglobulins, and 3 had plasmapheresis. Seventy-nine percent of patients were in Hughes GBS disability scale 4 to 5 at discharge and no patients died during the observation period. Acute ZIKV infection, confirmed by reverse transcriptase-polymerase chain reaction, was observed for 1 patient. CONCLUSIONS: All cases of this GBS outbreak had a recent history ZIKV infection, reinforcing existing evidence for the association between GBS and ZIKV. Future genetic and immunologic studies are warranted to further investigate the cause of the outbreak in detail.
Authors: Chelsea G Major; Emilio Dirlikov; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge Muñoz-Jordán; Candimar Colón-Sánchez; Myriam García-Negrón; Marangely Olivero-Segarra; Graciela Malavé-González; Dana L Thomas; Carlos A Luciano; Stephen H Waterman; James Sejvar; Tyler M Sharp; Brenda Rivera-García Journal: P R Health Sci J Date: 2018-12 Impact factor: 0.705
Authors: Emilio Dirlikov; Chelsea G Major; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge L Muñoz-Jordan; Candimar Colon-Sanchez; Myriam Garcia; Marangely Olivero-Segarra; Graciela Malave; Gloria M Rodríguez-Vega; Dana L Thomas; Stephen H Waterman; James J Sejvar; Carlos A Luciano; Tyler M Sharp; Brenda Rivera-García Journal: JAMA Neurol Date: 2018-09-01 Impact factor: 18.302
Authors: Daniel M Pastula; Julia C Durrant; Daniel E Smith; J David Beckham; Kenneth L Tyler Journal: Neurocrit Care Date: 2017-06 Impact factor: 3.532
Authors: Emilio Dirlikov; José V Torres; Roosecelis Brasil Martines; Sarah Reagan-Steiner; George Venero Pérez; Aidsa Rivera; Chelsea Major; Desiree Matos; Jorge Muñoz-Jordan; Wun-Ju Shieh; Sherif R Zaki; Tyler M Sharp Journal: Emerg Infect Dis Date: 2018-01 Impact factor: 6.883
Authors: Rahul Mittal; Desiree Nguyen; Luca H Debs; Amit P Patel; George Liu; Vasanti M Jhaveri; Sae-In S Kay; Jeenu Mittal; Emmalee S Bandstra; Ramzi T Younis; Prem Chapagain; Dushyantha T Jayaweera; Xue Zhong Liu Journal: Front Cell Infect Microbiol Date: 2017-12-08 Impact factor: 5.293